Yinghua Lang

3.6k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Yinghua Lang is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Yinghua Lang has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 12 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Yinghua Lang's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (9 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Yinghua Lang is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (9 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Yinghua Lang collaborates with scholars based in United States, Canada and Belgium. Yinghua Lang's co-authors include William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, Jean‐Frédéric Colombel, Colleen Marano, Bruce E. Sands, Gary R. Lichtenstein, Daniel H. Present, Stephen B. Hanauer and Walter Reinisch and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Yinghua Lang

15 papers receiving 1.3k citations

Hit Papers

Early Mucosal Healing With Infliximab Is Associated With ... 2011 2026 2016 2021 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
    2011 693 citations Jean‐Frédéric Colombel, Paul Rutgeerts et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinghua Lang United States 9 1.2k 974 431 303 125 15 1.4k
G. D’Haens Netherlands 12 985 0.8× 851 0.9× 380 0.9× 211 0.7× 122 1.0× 37 1.2k
Judith Collins United States 9 1.3k 1.0× 1.0k 1.1× 354 0.8× 357 1.2× 165 1.3× 18 1.7k
Reena Khanna Canada 21 969 0.8× 760 0.8× 264 0.6× 442 1.5× 89 0.7× 39 1.2k
B Huang Canada 9 893 0.7× 770 0.8× 269 0.6× 199 0.7× 117 0.9× 32 1.0k
Cathérine Reenaers Belgium 19 835 0.7× 671 0.7× 320 0.7× 222 0.7× 75 0.6× 63 1.1k
Sara Onali Italy 26 1.1k 0.9× 709 0.7× 514 1.2× 269 0.9× 116 0.9× 68 1.5k
Juan Ricardo Márquez Colombia 8 790 0.6× 628 0.6× 274 0.6× 199 0.7× 84 0.7× 24 952
Wendy Kampman United States 4 771 0.6× 650 0.7× 207 0.5× 201 0.7× 83 0.7× 8 903
Paul Pollack United States 10 1.4k 1.1× 1.1k 1.1× 440 1.0× 490 1.6× 93 0.7× 29 1.7k
Hanzhe Zheng United States 6 717 0.6× 572 0.6× 187 0.4× 214 0.7× 76 0.6× 13 895

Countries citing papers authored by Yinghua Lang

Since Specialization
Citations

This map shows the geographic impact of Yinghua Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghua Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghua Lang more than expected).

Fields of papers citing papers by Yinghua Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinghua Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghua Lang. The network helps show where Yinghua Lang may publish in the future.

Co-authorship network of co-authors of Yinghua Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Yinghua Lang. A scholar is included among the top collaborators of Yinghua Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinghua Lang. Yinghua Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rutgeerts, Paul, Christopher Gasink, Daphne Chan, et al.. (2018). Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease. Gastroenterology. 155(4). 1045–1058. 115 indexed citations
2.
Sands, Bruce E., Chenglong Han, Christopher Gasink, et al.. (2018). The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn’s Disease. Journal of Crohn s and Colitis. 12(8). 883–895. 23 indexed citations
3.
Sandborn, William J., C Gasink, Daphne Chan, et al.. (2016). Endoscopic Healing in Induction and Maintenance with Ustekinumab in the Phase 3 UNITI Crohnʼs Disease Program: 2016 ACG Presidential Poster Award. The American Journal of Gastroenterology. 111. S278–S279. 2 indexed citations
4.
5.
Sandborn, William J., Christopher Gasink, Marion Blank, et al.. (2016). O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohnʼs Disease Refractory to Anti-TFNα. Inflammatory Bowel Diseases. 22. S1–S1. 38 indexed citations
6.
7.
8.
Colombel, Jean‐Frédéric, Paul Rutgeerts, Walter Reinisch, et al.. (2011). Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis. Gastroenterology. 141(4). 1194–1201. 693 indexed citations breakdown →
9.
Reinisch, Walter, William J. Sandborn, Paul Rutgeerts, et al.. (2011). Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies. Inflammatory Bowel Diseases. 18(2). 201–211. 164 indexed citations
10.
Hyams, Jeffrey S., Thomas D. Walters, Wallace Crandall, et al.. (2011). Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension. Current Medical Research and Opinion. 27(3). 651–662. 79 indexed citations
11.
Rutgeerts, Paul, Walter Reinisch, Diederik Esser, et al.. (2011). A post-hoc analysis. Inflammatory Bowel Diseases. 17(suppl_1). S6–S6. 6 indexed citations
12.
Sandborn, William J., Paul Rutgeerts, Walter Reinisch, et al.. (2010). Mucosal Healing in Patients with Ulcerative Colitis Associates with a Reduced Colectomy Risk, High Incidence of Symptomatic Remission, and Corticosteroid-Free State. The American Journal of Gastroenterology. 105. S438–S439. 7 indexed citations
13.
Lichtenstein, Gary, Robert H. Diamond, Carrie Wagner, et al.. (2009). Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD‐subgroup analyses across four randomized trials. Alimentary Pharmacology & Therapeutics. 30(3). 210–226. 162 indexed citations
14.
Toedter, Gary, Marion Blank, Yinghua Lang, et al.. (2009). Relationship of C-Reactive Protein With Clinical Response After Therapy With Ustekinumab in Crohn's Disease. The American Journal of Gastroenterology. 104(11). 2768–2773. 53 indexed citations
15.
Sandborn, William J., Paul Rutgeerts, Brian G. Feagan, et al.. (2008). T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC). Gastroenterology. 134(4). A–492. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. D’Haens Breakdown of academic impact, for papers by Judith Collins Breakdown of academic impact, for papers by Reena Khanna Breakdown of academic impact, for papers by B Huang Breakdown of academic impact, for papers by Cathérine Reenaers Breakdown of academic impact, for papers by Sara Onali Breakdown of academic impact, for papers by Juan Ricardo Márquez Breakdown of academic impact, for papers by Wendy Kampman Breakdown of academic impact, for papers by Paul Pollack Breakdown of academic impact, for papers by Hanzhe Zheng
Rankless by CCL
2026